| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |